LIFE TECHNOLOGIES CORP Forms 3, 4 and 5: Restricted Stock Units and Performance Rights
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 76 rows in 2008. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2008-12-16: Reporting owner SHANAHAN WILLIAM S; Form 4; Security Restricted Stock Units; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2008-12-05: Reporting owner Miller John L; Form 4; Security Restricted Stock Units; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2008-12-04: Reporting owner Beery Joseph C; Form 3; Security Restricted Stock Units; Transaction Holding.
- 2008-11-30: Reporting owner BARTHELEMY NICOLAS; Form 4; Security Restricted Stock Unit; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2008-12-16 | SHANAHAN WILLIAM S Director | 4 | Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +3,021 3,021 owned after | $0.00 | 2008-12-18 | |
| 2008-12-05 | Miller John L Officer (President, Genetic Systems) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −30,000 0 owned after | $0.00 | 2008-12-09 | |
| 2008-12-04 holding as of filing | Beery Joseph C Officer (SVP, Chief Information Officer) | 3 | Restricted Stock Units Derivative · Direct | Holding | no price filed | 2008-12-04 | ||
| 2008-11-30 | BARTHELEMY NICOLAS Officer (President, Cell Systems) | 4 | Restricted Stock Unit Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,300 0 owned after | $0.00 | 2008-12-02 | |
| 2008-11-30 | Brust Bernd Officer (Pres, Commercial Operations) | 4 | Restricted Stock Unit Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,500 0 owned after | $0.00 | 2008-12-02 | |
| 2008-11-30 | Hoffmeister David F Officer (Chief Financial Officer) | 4 | Restricted Stock Unit Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,300 0 owned after | $0.00 | 2008-12-02 | |
| 2008-11-30 | COTTINGHAM JOHN A Officer (Chief Legal Officer) | 4 | Restricted Stock Unit Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,300 0 owned after | $0.00 | 2008-12-02 | |
| 2008-11-30 | Leddy Peter Michael Officer (SVP, Global Human Resources) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,300 0 owned after | $0.00 | 2008-12-02 | |
| 2008-11-30 | Miller John L Officer (President, Genetic Systems) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,500 0 owned after | $0.00 | 2008-12-02 | |
| 2008-11-25 holding as of filing | LONGFIELD WILLIAM H Director | 3 | Deferred Stock Unit Derivative · Direct | Holding | no price filed | 2008-11-25 | ||
| 2008-11-25 holding as of filing | LEVINE ARNOLD J Director | 3 | Deferred Stock Units Derivative · Direct | Holding | no price filed | 2008-11-25 | ||
| 2008-11-21 | Hoffmeister David F Officer (Chief Financial Officer) | 4 | Restricted Stock Unit Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +41,610 41,610 owned after | $0.00 | 2008-11-25 | |
| 2008-11-21 | Stevenson Mark Officer (President & COO) | 4 | Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +44,984 44,984 owned after | $0.00 | 2008-11-25 | |
| 2008-11-21 | O'Donnell Mark Sean Officer (SVP, Global Operations & Serv.) | 4 | Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +24,741 24,741 owned after | $0.00 | 2008-11-25 | |
| 2008-11-21 | Miller John L Officer (President - Genetic Systems) | 4 | Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +41,610 41,610 owned after | $0.00 | 2008-11-25 | |
| 2008-11-21 | LUCIER GREGORY T Officer (CEO) | 4 | Restricted Stock Unit Derivative · Indirect · by trust | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +161,943 161,943 owned after | $0.00 | 2008-11-25 | |
| 2008-11-21 | LONGFIELD WILLIAM H Director | 4 | Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +3,473 3,473 owned after | $0.00 | 2008-11-25 | |
| 2008-11-21 | LEVINE ARNOLD J Director | 4 | Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +3,473 3,473 owned after | $0.00 | 2008-11-25 | |
| 2008-11-21 | Leddy Peter Michael Officer (SVP, Human Resources) | 4 | Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +24,741 24,741 owned after | $0.00 | 2008-11-25 | |
| 2008-11-21 | Grossman Paul David Officer (SVP, Corporate Strategy & Dev.) | 4 | Restricted Stock units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +24,741 24,741 owned after | $0.00 | 2008-11-25 | |
| 2008-11-21 | Dansky Peter Officer (Pres, Molecular Biology Sys) | 4 | Restricted Stock Untis Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +41,610 41,610 owned after | $0.00 | 2008-11-25 | |
| 2008-11-21 | COTTINGHAM JOHN A Officer (Chief Legal Officer) | 4 | Restricted Stock Unit Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +24,741 24,741 owned after | $0.00 | 2008-11-25 | |
| 2008-11-21 | Brust Bernd Officer (Pres, Commercial Operations) | 4 | Restricted Stock Unit Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +41,610 41,610 owned after | $0.00 | 2008-11-25 | |
| 2008-11-21 | BENCHIMOL CLAUDE Officer (SVP, Advanced Genomic Systems) | 4 | Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +24,741 24,741 owned after | $0.00 | 2008-11-25 | |
| 2008-11-21 | BARTHELEMY NICOLAS Officer (President, Cell Systems) | 4 | Restricted Stock Unit Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +41,610 41,610 owned after | $0.00 | 2008-11-25 | |
| 2008-11-21 | ADAM GEORGE F JR Director | 4 | Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +3,473 3,473 owned after | $0.00 | 2008-11-25 | |
| 2008-11-14 | BARTHELEMY NICOLAS Officer (SVP, Cell Culture Systems) | 4 | Restricted Stock Unit Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,000 0 owned after | $0.00 | 2008-11-18 | |
| 2008-11-14 | Brust Bernd Officer (SVP, Worldwide Sales) | 4 | Restricted Stock Unit Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,000 0 owned after | $0.00 | 2008-11-18 | |
| 2008-11-14 | BENCHIMOL CLAUDE Officer (SVP, Advanced Genomic Systems) | 4 | Restricted Stock Unit Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −6,000 0 owned after | $0.00 | 2008-11-18 | |
| 2008-11-14 | COTTINGHAM JOHN A Officer (SVP, Gen Counsel & Secretary) | 4 | Restricted Stock Unit Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,000 0 owned after | $0.00 | 2008-11-18 | |
| 2008-11-14 | Hoffmeister David F Officer (Chief Financial Officer) | 4 | Restricted Stock Unit Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −9,000 0 owned after | $0.00 | 2008-11-18 | |
| 2008-11-14 | Leddy Peter Michael Officer (SVP, Human Resources) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | +2,000 0 owned after | $0.00 | 2008-11-18 | |
| 2008-11-14 | LUCIER GREGORY T Officer (CEO) | 4 | Restricted Stock Unit Derivative · Indirect · by trust | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −12,000 0 owned after | $0.00 | 2008-11-18 | |
| 2008-08-01 | RICHARD KELLI Officer (Chief Accounting Officer) | 4 | Restricted Stock units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,726 1,726 owned after | $0.00 | 2008-08-05 | |
| 2008-07-05 | Leddy Peter Michael Officer (SVP, Human Resources) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −40,000 0 owned after | $0.00 | 2008-07-08 | |
| 2008-05-15 | BARTHELEMY NICOLAS Officer (SVP, Cell Culture Systems) | 4 | Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,707 1,707 owned after | $0.00 | 2008-05-19 | |
| 2008-05-15 | BARTHELEMY NICOLAS Officer (SVP, Cell Culture Systems) | 4 | Performance Shares Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,707 1,707 owned after | $0.00 | 2008-05-19 | |
| 2008-05-15 | BENCHIMOL CLAUDE Officer (SVP, Research & Development) | 4 | Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,494 1,494 owned after | $0.00 | 2008-05-19 | |
| 2008-05-15 | BENCHIMOL CLAUDE Officer (SVP, Research & Development) | 4 | Performance Shares Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,494 1,494 owned after | $0.00 | 2008-05-19 | |
| 2008-05-15 | COTTINGHAM JOHN A Officer (SVP, Gen Counsel & Secretary) | 4 | Restricted Stock Unites Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,494 1,494 owned after | $0.00 | 2008-05-19 | |
| 2008-05-15 | COTTINGHAM JOHN A Officer (SVP, Gen Counsel & Secretary) | 4 | Performance Shares Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,494 1,494 owned after | $0.00 | 2008-05-19 | |
| 2008-05-15 | Brust Bernd Officer (SVP, Worldwide Sales) | 4 | Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,814 1,814 owned after | $0.00 | 2008-05-19 | |
| 2008-05-15 | Brust Bernd Officer (SVP, Worldwide Sales) | 4 | Performance Shares Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,814 1,814 owned after | $0.00 | 2008-05-19 | |
| 2008-05-15 | Grossman Paul David Officer (SVP, Corporate Strategy & Dev.) | 4 | Restricted Stock units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,600 1,600 owned after | $0.00 | 2008-05-19 | |
| 2008-05-15 | Grossman Paul David Officer (SVP, Corporate Strategy & Dev.) | 4 | Performance Shares Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,600 1,600 owned after | $0.00 | 2008-05-19 | |
| 2008-05-15 | Hoffmeister David F Officer (Chief Financial Officer) | 4 | Restricted Stock Units. Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,600 1,600 owned after | $0.00 | 2008-05-19 | |
| 2008-05-15 | Hoffmeister David F Officer (Chief Financial Officer) | 4 | Performance Shares. Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,600 1,600 owned after | $0.00 | 2008-05-19 | |
| 2008-05-15 | Leddy Peter Michael Officer (SVP, Human Resources) | 4 | Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,707 1,707 owned after | $0.00 | 2008-05-19 | |
| 2008-05-15 | Leddy Peter Michael Officer (SVP, Human Resources) | 4 | Performance Shares Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,707 1,707 owned after | $0.00 | 2008-05-19 | |
| 2008-05-15 | Miller John L Officer (SVP - BioDiscovery) | 4 | Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,814 1,814 owned after | $0.00 | 2008-05-19 | |
| 2008-05-15 | Miller John L Officer (SVP - BioDiscovery) | 4 | Performance Shares Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,814 1,814 owned after | $0.00 | 2008-05-19 | |
| 2008-05-15 | RICHARD KELLI Officer (Chief Accounting Officer) | 4 | Restricted Stock units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +533 533 owned after | $0.00 | 2008-05-19 | |
| 2008-05-13 | BENCHIMOL CLAUDE Officer (SVP, Research & Development) | 4 | Restricted Stock Unit Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,000 3,000 owned after | $0.00 | 2008-05-15 | |
| 2008-05-13 | BARTHELEMY NICOLAS Officer (SVP, Cell Culture Systems) | 4 | Restricted Stock Unit Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,000 3,000 owned after | $0.00 | 2008-05-15 | |
| 2008-05-13 | Brust Bernd Officer (SVP - Worldwide Sales) | 4 | Restricted Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −500 500 owned after | $0.00 | 2008-05-15 | |
| 2008-05-13 | COTTINGHAM JOHN A Officer (SVP, Gen Counsel & Secretary) | 4 | Restricted Stock Unit Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,500 1,500 owned after | $0.00 | 2008-05-15 | |
| 2008-05-13 | LUCIER GREGORY T Officer (CEO) | 4 | Restricted Stock Unit Derivative · Indirect · by trust | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −6,000 6,000 owned after | $0.00 | 2008-05-15 | |
| 2008-05-13 | Hoffmeister David F Officer (Chief Financial Officer) | 4 | Restricted Stock Unit Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,500 4,500 owned after | $0.00 | 2008-05-15 | |
| 2008-04-30 | MATRICARIA RONALD A Director | 4 | Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,871 6,485 owned after | $0.00 | 2008-05-29 | |
| 2008-04-30 | PETERSON PER A Director | 4 | Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,871 4,622 owned after | $0.00 | 2008-05-19 | |
| 2008-04-30 | GRIMM DONALD W Director | 4 | Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,871 6,485 owned after | $0.00 | 2008-05-16 | |
| 2008-04-30 | UPRICHARD DAVID C Director | 4 | Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,871 6,485 owned after | $0.00 | 2008-05-16 | |
| 2008-04-30 | LORIMIER BRADLEY G Director | 4 | Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,871 6,485 owned after | $0.00 | 2008-05-16 | |
| 2008-04-30 | DITTAMORE RAYMOND V Director | 4 | Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,871 6,485 owned after | $0.00 | 2008-05-16 | |
| 2008-04-30 | REYNOLDS W ANN Director | 4 | Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,871 6,677 owned after | $0.00 | 2008-05-16 | |
| 2008-04-30 | IYER BALAKRISHNAN S Director | 4 | Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,871 6,485 owned after | $0.00 | 2008-05-16 | |
| 2008-04-25 | GIBSON KAREN Officer (Chief Information Officer) | 4 | Restricted Stock Award Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −6,383 0 owned after | $0.00 | 2008-04-29 | |
| 2008-04-23 | BARTHELEMY NICOLAS Officer (SVP, Cell Culture Systems) | 4 | Restricted Stock Award Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,500 0 owned after | $0.00 | 2008-04-25 | |
| 2008-03-27 | BARTHELEMY NICOLAS Officer (SVP, Cell Culture Systems) | 4 | Restricted Stock Award Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,500 2,500 owned after | $0.00 | 2008-03-27 | |
| 2008-03-14 | Miller John L Officer (President - Genetic Systems) | 4 | Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,815 1,815 owned after | $0.00 | 2008-11-25 | |
| 2008-03-14 | BARTHELEMY NICOLAS Officer (SVP, Cell Culture Systems) | 4 | Restricted Stock Unit Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +3,230 3,230 owned after | $0.00 | 2008-11-18 | |
| 2008-03-14 | Brust Bernd Officer (SVP, Worldwide Sales) | 4 | Restricted Stock Unit Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +4,582 4,582 owned after | $0.00 | 2008-11-18 | |
| 2008-03-14 | COTTINGHAM JOHN A Officer (SVP, Gen Counsel & Secretary) | 4 | Restricted Stock Unit Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +3,152 3,152 owned after | $0.00 | 2008-11-18 | |
| 2008-03-14 | Hoffmeister David F Officer (Chief Financial Officer) | 4 | Restricted Stock Unit Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +3,660 3,660 owned after | $0.00 | 2008-11-18 | |
| 2008-03-14 | Leddy Peter Michael Officer (SVP, Human Resources) | 4 | Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +3,234 3,234 owned after | $0.00 | 2008-11-18 | |
| 2008-03-14 | LUCIER GREGORY T Officer (CEO) | 4 | Restricted Stock Unit Derivative · Indirect · by trust | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +22,532 22,532 owned after | $0.00 | 2008-11-18 |